Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8995)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Einama T, Kawamata F, Kamachi H, Nishihara H, Homma S, Matsuzawa F, Mizukami T, Konishi Y, Tahara M, Kamiyama T, Hino O, Taketomi A, Todo S. Clinical impacts of mesothelin expression in gastrointestinal carcinomas. World J Gastrointest Pathophysiol 2016; 7(2): 218-222 [PMID: 27190694 DOI: 10.4291/wjgp.v7.i2.218] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v7/i2/218.htm |
| Number | Citing Articles |
| 1 |
Federico Nichetti, Antonio Marra, Francesca Corti, Alessandro Guidi, Alessandra Raimondi, Natalie Prinzi, Filippo de Braud, Sara Pusceddu. The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review. Targeted Oncology 2018; 13(3): 333 doi: 10.1007/s11523-018-0567-0
|
| 2 |
Xudong Wang, Wenzong Ma, Weihao Liu, Huan Ma, Yuanyou Yang, Yugang Wang, Ning Liu, Gen Yang. Construction and Preclinical Evaluation of 211At Labeled Anti-mesothelin Antibodies as Potential Targeted Alpha Therapy Drugs. Journal of Radiation Research 2020; 61(5): 684 doi: 10.1093/jrr/rraa049
|
| 3 |
Soichiro Kakimoto, Morikazu Miyamoto, Takahiro Einama, Hiroko Matsuura, Hideki Iwahashi, Hiroki Ishibashi, Takahiro Sakamoto, Taira Hada, Masashi Takano. Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma. Pathology & Oncology Research 2020; 26(4): 2299 doi: 10.1007/s12253-020-00823-1
|
| 4 |
Andrew D.J. Pearson, C.Michel Zwaan, E.Anders Kolb, Dominik Karres, Julie Guillot, Su Young Kim, Lynley Marshall, Sarah K. Tasian, Malcolm Smith, Todd Cooper, Peter C. Adamson, Elly Barry, Bouchra Benettaib, Florence Binlich, Anne Borgman, Erica Brivio, Renaud Capdeville, David Delgado, Douglas Faller, Linda Fogelstrand, Paula Goodman Fraenkel, Henrik Hasle, Delphine Heenen, Gertjan Kaspers, Mark Kieran, Jan-Henning Klusmann, Giovanni Lesa, Franca Ligas, Silvia Mappa, Hesham Mohamed, Andrew Moore, Joan Morris, Kerri Nottage, Dirk Reinhardt, Nicole Scobie, Stephen Simko, Thomas Winkler, Koen Norga, Gregory Reaman, Gilles Vassal. Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents. European Journal of Cancer 2020; 136: 116 doi: 10.1016/j.ejca.2020.04.038
|
| 5 |
Fumihiko Matsuzawa, Hirofumi Kamachi, Tatsuzo Mizukami, Takahiro Einama, Futoshi Kawamata, Yuki Fujii, Moto Fukai, Nozomi Kobayashi, Yutaka Hatanaka, Akinobu Taketomi. Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-020-07722-3
|
| 6 |
Michel Fausther, Elise G. Lavoie, Jonathan A. Dranoff, Heather Francis. Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants*. PLOS ONE 2017; 12(9): e0184499 doi: 10.1371/journal.pone.0184499
|
| 7 |
Davinder Singh, Divya Dheer, Abhilash Samykutty, Ravi Shankar. Antibody drug conjugates in gastrointestinal cancer: From lab to clinical development. Journal of Controlled Release 2021; 340: 1 doi: 10.1016/j.jconrel.2021.10.006
|
| 8 |
Radhika Theresa Tandon, Yuis Jimenez-Cortez, Robert Taub, Alain C. Borczuk. Immunohistochemistry in Peritoneal Mesothelioma: A Single-Center Experience of 244 Cases. Archives of Pathology & Laboratory Medicine 2018; 142(2): 236 doi: 10.5858/arpa.2017-0092-OA
|
| 9 |
Korinna Jöhrens, Lea Lazzerini, Jana Barinoff, Jalid Sehouli, Guenter Cichon. Mesothelin as a target for cervical cancer therapy. Archives of Gynecology and Obstetrics 2019; 299(1): 211 doi: 10.1007/s00404-018-4933-z
|
| 10 |
Xiaoxiao Duan, Linlin Zhao, Heng Dong, Wang Zhao, Sixiu Liu, Guodong Sui. Microfluidic Immunoassay System for Rapid Detection and Semi-Quantitative Determination of a Potential Serum Biomarker Mesothelin. ACS Sensors 2019; 4(11): 2952 doi: 10.1021/acssensors.9b01430
|
| 11 |
Hyunsung Kim, Yumin Chung, Seung Sam Paik, Kiseok Jang, Su-Jin Shin. Mesothelin expression and its prognostic role according to microsatellite instability status in colorectal adenocarcinoma. Medicine 2019; 98(26): e16207 doi: 10.1097/MD.0000000000016207
|
| 12 |
Takahiro Einama, Futoshi Kawamata, Hirofumi Kamachi, Hiroshi Nishihara, Shigenori Homma, Fumihiko Matsuzawa, Tatsuzo Mizukami, Yuji Konishi, Toshiya Kamiyama, Junji Yamamoto, Akinobu Taketomi, Satoru Todo. Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors. EBioMedicine 2017; 24: 16 doi: 10.1016/j.ebiom.2017.09.033
|
| 13 |
Xingguo Hou, Feng Wang, Xiangxi Meng, Dan Li, Jin Ding, Yan Chen, Zilei Wang, Hua Zhu, Zhi Yang. Construction of a 124I-Labeled Specific Antibody for the Noninvasive Detection of Mesothelin-Overexpressing Tumors. Molecular Pharmaceutics 2022; 19(10): 3623 doi: 10.1021/acs.molpharmaceut.2c00342
|
| 14 |
Dong H. Yoon, Ahmad Ibrahim, Sergei Tatishchev, Marjun P. N. Duldulao, Sang W. Lee, Joongho Shin. Prevalence of mesothelin expression in peritoneal disease from colorectal and appendiceal cancers. Journal of Surgical Oncology 2021; 124(7): 1091 doi: 10.1002/jso.26610
|
| 15 |
Muhammad Yasir Anwar, Grant R. Williams, Ravi K. Paluri. CAR T Cell Therapy in Pancreaticobiliary Cancers: a Focused Review of Clinical Data. Journal of Gastrointestinal Cancer 2021; 52(1): 1 doi: 10.1007/s12029-020-00457-1
|